Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Insulin for GI Maturation in Preterm Infants
NCT01093638Phase 2Terminated
- Sponsor
- Elgan Pharma
- Start
- Aug 2010
- Primary completion
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of regular human insulin in intestinal malabsorption, feeding intolerance, sponsored by Elgan Pharma. Started Aug 2010; status: terminated.
02
Drugs
regular human insulin
03
Conditions
intestinal malabsorptionfeeding intolerance
Beyond the preview
Go deeper on NCT01093638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01093638.